Study Condition(s): Soft Tissue Sarcoma

A Study of Olaratumab (LY3012207) in Participants With Soft Tissue Sarcoma

Study Alias: JGDM

Study Identifier(s): Tool Tip Icon {{ defaultRegistry.registryAnchorText }} NCT02783599 {{ currentLocaleObject.registryAnchorText }}

Study Purpose

The purpose of this study is to evaluate potential biomarkers and method of action, efficacy and safety of olaratumab in participants with soft tissue sarcoma (STS).

Completed Study

The results of this study are not yet available.

Who Participated? Tool Tip Icon

Here you can find out a bit more about the requirements for volunteers who took part in this study

Gender

Male Female

Age

18+ years

Time Commitment

Your participation could last up to 25 weeks depending on how you and your tumor respond.
  • Participant must have a diagnosis of Soft Tissue Sarcoma (STS) confirmed by histology
  • Participant must not have Kaposi's sarcoma or gastrointestinal stromal tumors (GIST)
  • Participant must agree to undergo 2 mandatory tissue biopsies
  • Participant must not have active central nervous system (CNS) or leptomeningeal metastasis (brain metastasis) at the time of enrollment
  • Participant must not have received prior treatment with doxorubicin, epirubicin, idarubicin, and/or other anthracyclines or anthracenediones
  • Participant must not have received treatment with olaratumab or have participated in a prior olaratumab trial

Where This Study Took Place Tool Tip Icon

13 locations participated
Invalid Postal Code.
Please re-enter postal code.

{{sites.getPageStartCount()}} - {{sites.getPageEndCount()}} of {{sites.totalCount}} Results

0 of {{sites.totalCount}} Results

Distance Location
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
,
Closest Location
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
,
Other Location(s)
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
,

To improve your experience on Lilly TrialGuide, please use the latest version of Chrome, Firefox, Safari, or Internet Explorer, with Java Script enabled.
This website is not optimized for your browser, as configured.